Delivery Order SPE2DB22D3301-SPE2DB25FY9WP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on August 13, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 14, 2025. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $3,379.08 delivery order to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. Trokendi XR is a brand-name neurological medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 24, 2025, with completion expected by July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $4,622.34 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units). This non-set-aside contract was competitively awarded and is scheduled for completion by August 21, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,505.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 capsules of Trokendi XR 200 mg, with an ultimate completion date of August 4, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical supply delivery under the company's broader federal contract portfolio supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,966.96 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania facility. Trokendi XR is a branded anticonvulsant medication commonly used for seizure management and migraine prevention...
- The Defense Logistics Agency awarded a $1,144.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50mg Trokendi XR capsules. Under this single award, Amerisourcebergen will deliver 30 capsules to a facility in Conshohocken, Pennsylvania by August 9th, 2023, fulfilling DLA's requirement for this pharmaceutical product. As the prime contractor, Amerisourcebergen will perform the order itself without involvement of major subcontractors. This delivery order was issued...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $179 to Amerisourcebergen Drug Corporation to supply 30 capsules of Trokendi XR 25 mg on August 23, 2023. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation or whether this order is associated with any particular contract vehicle. As a major provider of pharmaceuticals and medical supplies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,133.52, is a Firm Fixed Price Delivery Order for the provision of Trokendi XR 100 mg capsules. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY9WPDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,727.33 for Trokendi XR 100 mg capsules (30-count) under a firm fixed-price contract type. This delivery order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-set-aside award made through competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value and extends through December 2026. The prime IDV serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The Trokendi XR delivery represents one of numerous pharmaceutical transactions the company fulfills through this vehicle, which includes specialty medications, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.7k | 8/22/25 |